Anti-Spike-RBD-human-mAb(IgM) |
E24AHA005 |
EnoGene |
Humanized-Monoclonal-Antibody.human-IgM |
EUR 416.5 |
Description: Humanized Monoclonal Antibody.human IgM |
Human IgG antibody Laboratories manufactures the mouse igm antibody to human rbd-spike? reagents distributed by Genprice. The Mouse Igm Antibody To Human Rbd-Spike? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Mouse products are available in stock. Specificity: Mouse Category: Igm Group: Antibody To
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
GENLISA Human Anti-SARS-CoV-2 IgG Antibody to Spike RBD Protein ELISA (Quantitative) - CE MARKED |
Krishgen |
1 x 96 wells |
EUR 379.5 |
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) |
ACROBIOSYSTEMS |
100ug |
EUR 2974.6 |
|
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM (AM122) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). |
SARS-CoV-2 Spike RBD Protein IgG Antibody ELISA Kit |
Abclonal |
96T |
EUR 280 |
SARS-CoV-2-Spike-RBD-Antibody |
EnoGene |
N/A |
EUR 346.5 |
Description: N/A |
Anti-Spike-RBD-Antibody(R15-F7) |
EnoGene |
N/A |
EUR 157.5 |
Description: N/A |
GENLISA Rat Anti-SARS-CoV-2 IgG Antibody to Spike RBD protein Quantitative TITRATION ELISA |
Krishgen |
1 x 96 wells |
EUR 550 |
Antibody To information
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1 |
Jotbody |
each |
Ask for price |
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1-100 |
Jotbody |
100 |
EUR 148.12 |
Description: Primary VHH single domain antibody |
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1-1000 |
Jotbody |
1000 |
EUR 880.6 |
Description: Primary VHH single domain antibody |
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1-2000 |
Jotbody |
2000 |
EUR 1565.2 |
Description: Primary VHH single domain antibody |
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1-250 |
Jotbody |
250 |
EUR 246.17 |
Description: Primary VHH single domain antibody |
anti-SARS-CoV-2 spike RBD VHH antibody |
JOT0007-1-50 |
Jotbody |
50 |
EUR 89.54 |
Description: Primary VHH single domain antibody |
SARS-CoV-2 (COVID-19) Spike RBD Antibody |
9087-002mg |
ProSci |
0.02 mg |
EUR 229.7 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Spike RBD Antibody |
9087-01mg |
ProSci |
0.1 mg |
EUR 594.26 |
|
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
GENLISA Human Anti-SARS-CoV-2 IgM Antibody To Spike Protein Protein ELISA |
KBVH015-19 |
Krishgen |
1 x 96 wells |
EUR 500.5 |
Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35) |
SAD-S35 |
ACROBIOSYSTEMS |
100ug |
EUR 2974.6 |
|
Description: Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG1 (AS35) (SAD-S35) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 1.47 μg/mL using SARS-CoV-2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein. |
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12490-100 |
The Native Antigen Company |
0.1 |
EUR 375.07 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (CH1) |
MAB12490-500 |
The Native Antigen Company |
0.5 |
EUR 1757.98 |
Description: Recombinant humanised version of the mouse monoclonal antibody MAB12447. Antibody is specific for SARS-CoV-2 spike subunit 2 protein. |
Anti-SARS-CoV-2 Spike RBD Antibody, Mouse IgG1 (AS113) (Omicron Specific) |
SPD-M305 |
ACROBIOSYSTEMS |
100ug |
EUR 5927.8 |
|
Description: The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Spike RBD. The antibody is specific against the Omicron (B.1.1.529/BA.1) variant of SARS-CoV-2, and has no binding with the spike RBD of the wild type virus and other viral lineages. |
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (AD10) |
MAB12492-100 |
The Native Antigen Company |
0.1 |
EUR 413.34 |
Description: Recombinant humanized monoclonal antibody of the mouse monoclonal antibody MAB12446, against SARS-CoV-2 spike subunit 2 (S2) protein. |
Human IgM Anti SARS-CoV-2 Spike (S2) Antibody (AD10) |
MAB12492-500 |
The Native Antigen Company |
0.5 |
EUR 1757.98 |
Description: Recombinant humanized monoclonal antibody of the mouse monoclonal antibody MAB12446, against SARS-CoV-2 spike subunit 2 (S2) protein. |
Human IgM Anti SARS-CoV-2 Spike (S1) Antibody (CR3022) |
MAB12423-50 |
The Native Antigen Company |
0.05 |
EUR 1077.3 |
Description: This is a recombinant monoclonal antibody. It is a reformatted human antibody made using the variable domain sequences of the original Human IgG1 format. |
Human Anti-SARS-CoV-2 Spike RBD Antibody-coupled Magnetic Beads |
MBS-K014 |
ACROBIOSYSTEMS |
2mg |
EUR 2707.1 |
|
Description: The Human Anti-SARS-CoV-2 Spike RBD Antibody-coupled Magnetic Beads is produced by coupling biotinylated anti-RBD antibody to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing spike protein from your sample with high specificity. The uniform size and large surface-to-volume ratio of the beads ensure highly efficent immunocapture in a simple, fast and convenient workflow with high reproducibilty of data. |